Literature DB >> 19957002

The prognostic factors of systemic sclerosis for survival among Koreans.

Jinhyun Kim1, Sue Kyung Park, Ki Won Moon, Eun Young Lee, Yun Jong Lee, Yeong Wook Song, Eun Bong Lee.   

Abstract

Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by fibrosis of the skin and internal organs, which can cause significant morbidity and mortality. The prognostic factors for survival were not fully evaluated in Asian population. We investigated the prognostic factors for survival of SSc among Korean patients. A total of 243 SSc patients were enrolled from Seoul National University Hospital between 1972 and 2007. Age at onset, gender, cutaneous subset, autoantibody status, major organ involvement, and occurrence of malignancy were evaluated with all-cause mortality as the end point. A multivariate Cox proportional hazard model was used to retrieve the prognostic factors for survival. During the follow-up of 1,967 person-years, 33 patients died. Old age at onset (hazard ratio [HR] 7.4, 95% confidence interval [95% CI] 1.9-28.1), diffuse cutaneous subset (HR 2.5, 95% CI 1.1-5.9), presence of anti-Scl-70 antibody (HR 3.0, 95% CI 1.2-7.1), forced vital capacity less than 70% (HR 2.8, 95% CI 1.3-6.2), and heart involvement (HR 4.2, 95% CI 1.7-10.2) were found to be significant risk factors for mortality in multivariate analysis. In Korean SSc patients, old age, diffuse cutaneous involvement, anti-Scl-70 antibody, and internal organ involvement are risk factors for mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19957002     DOI: 10.1007/s10067-009-1324-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

Review 1.  Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

Authors:  Clodoveo Ferri; Gabriele Valentini; Franco Cozzi; Marco Sebastiani; Claudio Michelassi; Giovanni La Montagna; Arianna Bullo; Massimiliano Cazzato; Enrico Tirri; Franca Storino; Dilia Giuggioli; Giovanna Cuomo; Mara Rosada; Stefano Bombardieri; Silvano Todesco; Giuseppe Tirri
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.

Authors:  C P Simeon; L Armadans; V Fonollosa; M Vilardell; J Candell; C Tolosa; F Mearin; M J Rodrigo; R Solans; J Lima; G Sampol
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

Review 4.  Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.

Authors:  Eduardo J Cepeda; John D Reveille
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006

5.  Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)

Authors:  S Jacobsen; P Halberg; S Ullman
Journal:  Br J Rheumatol       Date:  1998-07

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Survival and causes of death in 366 Hungarian patients with systemic sclerosis.

Authors:  L Czirják; G Kumánovics; C Varjú; Z Nagy; A Pákozdi; Z Szekanecz; G Szucs
Journal:  Ann Rheum Dis       Date:  2007-05-22       Impact factor: 19.103

Review 8.  Genetics and genomic studies in scleroderma (systemic sclerosis).

Authors:  Sandeep K Agarwal; Filemon K Tan; Frank C Arnett
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

9.  Mortality and prognostic factors in Spanish patients with systemic sclerosis.

Authors:  C P Simeón; L Armadans; V Fonollosa; R Solans; A Selva; M Villar; J Lima; J Vaqué; M Vilardell
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

10.  Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.

Authors:  Eric Hachulla; Patrick Carpentier; Virginie Gressin; Elisabeth Diot; Yannick Allanore; Jean Sibilia; David Launay; Luc Mouthon; Patrick Jego; Jean Cabane; Pascal de Groote; Amélie Chabrol; Isabelle Lazareth; Loïc Guillevin; Pierre Clerson; Marc Humbert
Journal:  Rheumatology (Oxford)       Date:  2009-01-27       Impact factor: 7.580

View more
  6 in total

1.  Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Fahd Wafki; Fatima Znat; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

2.  Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.

Authors:  Meihua Qiu; Xueyuan Nian; Lingling Pang; Pengfei Yu; Shenchun Zou
Journal:  Int J Rheum Dis       Date:  2021-08-21       Impact factor: 2.558

3.  Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.

Authors:  Hadi Poormoghim; Elham Andalib; Arash Jalali; Afshin Ghaderi; Ali Ghorbannia; Nazanin Mojtabavi
Journal:  Rheumatol Int       Date:  2016-04-09       Impact factor: 2.631

4.  Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study.

Authors:  Suparaporn Wangkaew; Narawudt Prasertwitayakij; Arintaya Phrommintikul; Saowanee Puntana; Juntima Euathrongchit
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

5.  Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.

Authors:  M R Pokeerbux; J Giovannelli; L Dauchet; L Mouthon; C Agard; J C Lega; Y Allanore; P Jego; B Bienvenu; S Berthier; A Mekinian; E Hachulla; D Launay
Journal:  Arthritis Res Ther       Date:  2019-04-03       Impact factor: 5.156

6.  Development and validation of machine learning for early mortality in systemic sclerosis.

Authors:  Chingching Foocharoen; Wilaiphorn Thinkhamrop; Nathaphop Chaichaya; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Bandit Thinkhamrop
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.